Budagova T, Efremova A, Usman N, Mokrousova D, Goldshtein D
Int J Mol Sci. 2025; 26(3).
PMID: 39940874
PMC: 11816922.
DOI: 10.3390/ijms26031107.
Wawrety W, Kedziora A
Iran J Basic Med Sci. 2025; 28(3):273-282.
PMID: 39906620
PMC: 11790194.
DOI: 10.22038/ijbms.2024.77667.16798.
Agrawal P, Olgun G, Singh A, Gopalan V, Hannenhalli S
Comput Struct Biotechnol J. 2025; 27:252-264.
PMID: 39866667
PMC: 11763893.
DOI: 10.1016/j.csbj.2024.12.025.
Wagih N, Abdel-Rahman I, El-Koussi N, Abuo-Rahma G
RSC Adv. 2025; 15(2):966-1010.
PMID: 39807197
PMC: 11726184.
DOI: 10.1039/d4ra05014b.
Padzinska-Pruszynska I, Taciak B, Kiraga L, Smolarska A, Gorczak M, Kucharzewska P
Int J Mol Sci. 2025; 25(24.
PMID: 39769334
PMC: 11679359.
DOI: 10.3390/ijms252413569.
Senolytics: charting a new course or enhancing existing anti-tumor therapies?.
Czajkowski K, Herbet M, Murias M, Piatkowska-Chmiel I
Cell Oncol (Dordr). 2024; .
PMID: 39633108
DOI: 10.1007/s13402-024-01018-5.
A Study of the Bioactive Compounds, Antioxidant Capabilities, Antibacterial Effectiveness, and Cytotoxic Effects on Breast Cancer Cell Lines Using an Ethanolic Extract from the Aerial Parts of the Indigenous Plant Coss. & Moq.
Laaraj S, Tikent A, Chebaibi M, Bouaouda K, Bouhrim M, Sweilam S
Curr Issues Mol Biol. 2024; 46(11):12375-12396.
PMID: 39590329
PMC: 11592469.
DOI: 10.3390/cimb46110735.
Case Report: The role of and treatment in the management of radiotherapy and chemotherapy side effects in infiltrative ductal carcinoma.
Sawarkar P, Sawarkar G, Bhojraj N
F1000Res. 2024; 12:1383.
PMID: 39524546
PMC: 11544198.
DOI: 10.12688/f1000research.139233.2.
Family Malvaceae: a potential source of secondary metabolites with chemopreventive and anticancer activities supported with pharmacokinetic and pharmacodynamic profiles.
Sameh S, Elissawy A, Al-Sayed E, M Labib R, Chang H, Yu S
Front Pharmacol. 2024; 15:1465055.
PMID: 39478959
PMC: 11521888.
DOI: 10.3389/fphar.2024.1465055.
Characterizing the role of exosomal miRNAs in metastasis.
Agrawal P, Olgun G, Singh A, Gopalan V, Hannenhalli S
bioRxiv. 2024; .
PMID: 39372783
PMC: 11451750.
DOI: 10.1101/2024.08.20.608894.
Resistance Management for Cancer: Lessons from Farmers.
Seyedi S, Harris V, Kapsetaki S, Narayanan S, Saha D, Compton Z
Cancer Res. 2024; 84(22):3715-3727.
PMID: 39356625
PMC: 11565176.
DOI: 10.1158/0008-5472.CAN-23-3374.
Recent Advances and Mechanisms of Phage-Based Therapies in Cancer Treatment.
Ooi V, Yeh T
Int J Mol Sci. 2024; 25(18).
PMID: 39337427
PMC: 11432602.
DOI: 10.3390/ijms25189938.
Investigation of therapeutic potential of the Il24-p20 fusion protein against breast cancer: an in-silico approach.
Qureshi S, Ahmed N, Rehman H, Amirzada M, Saleem F, Waheed K
In Silico Pharmacol. 2024; 12(2):84.
PMID: 39301086
PMC: 11408464.
DOI: 10.1007/s40203-024-00252-x.
Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review.
Balasubramanian A, Veluswami K, Rao S, Aggarwal S, Mani S
Cureus. 2024; 16(7):e64324.
PMID: 39130943
PMC: 11316854.
DOI: 10.7759/cureus.64324.
Digital therapeutics and its role in cancer treatment management: current development and future scope.
Vikram Singh A
Rev Assoc Med Bras (1992). 2024; 70(6):e20240183.
PMID: 39045968
PMC: 11288262.
DOI: 10.1590/1806-9282.20240183.
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy.
Hsu C, Abdulrahim M, Mustafa M, Omar T, Balto F, Pineda I
Med Oncol. 2024; 41(8):202.
PMID: 39008137
DOI: 10.1007/s12032-024-02435-0.
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells.
Garg P, Malhotra J, Kulkarni P, Horne D, Salgia R, Singhal S
Cancers (Basel). 2024; 16(13).
PMID: 39001539
PMC: 11240358.
DOI: 10.3390/cancers16132478.
Tumor-Agnostic Therapy-The Final Step Forward in the Cure for Human Neoplasms?.
El-Sayed M, Bianco J, Li Y, Fabian Z
Cells. 2024; 13(12.
PMID: 38920700
PMC: 11201516.
DOI: 10.3390/cells13121071.
Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents.
Madan V, Ortiz-Lopez L, Sakunchotpanit G, Chen R, Nayudu K, Nambudiri V
Dermatol Ther (Heidelb). 2024; 14(7):1755-1766.
PMID: 38907875
PMC: 11264497.
DOI: 10.1007/s13555-024-01198-w.
Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review.
Dilenko H, Barton Tomankova K, Valkova L, Hosikova B, Kolarikova M, Malina L
Int J Nanomedicine. 2024; 19:5637-5680.
PMID: 38882538
PMC: 11179671.
DOI: 10.2147/IJN.S461300.